Menu

Directory Profile

Meagan  Whisenant

Meagan Whisenant, PhD, RN

Assistant Professor
Department of Research
713-500-2005
SON 580E
Meagan.Whisenant@uth.tmc.edu
View Curriculum Vitae

Meagan Whisenant, PhD, RN, has worked in oncology nursing for more than 15 years, in both inpatient and outpatient settings. Dr. Whisenant studies symptoms associated with cancer disease and treatment. Her work involves studying the measurement of cancer disease- and treatment-related symptoms, variability in symptom trajectories, and methods for implementing routine symptom monitoring and management in clinical care, including patient-reported outcomes (PRO) instrument development and testing. She utilizes both qualitative and quantitative methods to learn about the symptom experience from the patient and family caregiver perspective and consider approaches for monitoring and managing symptoms across the cancer trajectory.  


Related News Items


Publication: Caregiver bereavement following the death of glioma patients (May 2022)

Advancing HIV research and education (Apr 2022)

Publication: Characterization of symptoms and symptom clusters for type 2 diabetes mellitus using a large nationwide EHR database (Mar 2022)

Publication: Analysis of symptom communication in women with breast cancer receiving treatment (Dec 2021)

Publication: The unique symptom burden of patients receiving CAR T-cell therapy (Dec 2021)

Publication: Identification of breast cancer survivors with high symptom burden (Dec 2021)

Cizik School of Nursing Researcher to Study Symptom Management of HIV Positive Patients (Oct 2021)

Publication: Patient-reported symptom and functioning status during the first 12 months after CAR T-cell therapy for hematological malignancies (Sep 2021)

Publication: Preferences of Individuals with Cancer for Patient-Reported Outcome Measures (Feb 2021)

Grant launches research into COVID-19 symptoms among cancer patients (Aug 2020)

(Publication) What Do Patients With Non–Small-Cell Lung Cancer Experience? Content Domain for the MD Anderson Symptom Inventory for Lung Cancer (Jul 2020)